Skip to content

News

BRCA1/2 testing landscape finds dropping prices

Oct 15, 2015

TRANSPERS Finds that Cost-Effectiveness of Most Clinically Actionable Genetic Findings that ACMG Recommends for Return Has Not Been Evaluated In Economic Studies

Sep 30, 2015

New TRANSPERS Publication in Nature Biotechnology Finds Dropping Prices and Lack of Payer Coverage for Multi-Gene Panels that include BRCA1/2

Sep 28, 2015

TRANSPERS goes to Washington

Apr 14, 2015

TRANSPERS Director Kathryn Phillips is working with the Patient-Centered Outcomes Research Institute (PCORI)

Apr 14, 2015

Evaluating insurer coverage policies regarding tumor sequencing panels

Mar 16, 2015

Determining the full benefits and costs of sequencing

Feb 01, 2015

Consumers don’t know about or trust personalized medicine

Jan 21, 2015

TRANSPERS to build registry that will shed light on payers’ payment policies for new genetic tests

Dec 03, 2014

Making sense of sequencing

Jul 15, 2014

Pages